Results 21 to 30 of about 16,553 (172)
El sarcoma de Kaposi ó reticuloendoteliosis angiógena, como también se conoce a esta entidad dermatológica, fue descrito por primera vez por Moritz Kaposi en 1872 y por un siglo fue una enfermedad rara de varones ancianos.
Aracelys Alonso Álvarez+3 more
core +1 more source
Conjunctival Kaposi's Sarcoma. An Unusual AIDS Presentation [PDF]
O sarcoma de Kaposi ocular isolado surge em 0,3% a 5% dos doentes com SIDA, mas, em doentes com tumor disseminado, esta incidência aumenta para 15% a 20%. Apresentamos um caso de sarcoma de Kaposi epidémico, mucocutâneo, cuja primeira manifestação foi
Carmona, M+6 more
core
Structure and Antigenicity of Kaposi's Sarcoma‐Associated Herpesvirus Glycoprotein B
Kaposi's sarcoma‐associated herpesvirus (KSHV) causes severe cancers without effective treatments. This study presents an atomic model of KSHV's critical infection protein, gB, revealing a unique structure shared with related herpesviruses like Epstein‐Barr virus (EBV). The structural similarity highlights vulnerable targets for antibodies, guiding the
Xin‐Yan Fang+8 more
wiley +1 more source
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska+2 more
wiley +1 more source
Kaposi’s Sarcoma in Film [PDF]
[ES] El sarcoma de Kaposi, una enfermedad maligna cutánea, históricamente infrecuente, de curso indolente que afectaba a hombres de edad avanzada, emergió en los años 80 como una manifestación cutánea frecuente y fácilmente reconocible del Síndrome de ...
Holliday, Alex C.+1 more
core
Abstract Pre‐exposure prophylaxis (PrEP) is an antiretroviral drug that effectively prevents an HIV infection, which German statutory health insurance has covered since 2019. The drug's use in Germany has (re)surfaced ambivalent emotions: hopes for an HIV/AIDS‐free future and sexual liberation rub against enduring worries and moralizations of ...
Max Schnepf
wiley +1 more source
HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India. [PDF]
We utilized computerized record-linkage methods to link HIV and cancer databases with limited unique identifiers in Pune, India, to determine feasibility of linkage and obtain preliminary estimates of cancer risk in persons living with HIV (PLHIV) as ...
Bhatia, Kishor+13 more
core +1 more source
Plaque‐Like Dermatofibroma: A Case Report and a Review of the Literature With a Focus on Dermoscopy
ABSTRACT Plaque‐like dermatofibroma (PLDF) is a rare clinical variant of dermatofibroma (DF), characterised by flat, infiltrative lesions, often larger than 50 mm in diameter and located on the trunk or lower extremities. A 44‐year‐old male presented to our clinic with a 20 cm brownish plaque with peripheral satellite lesions on the right antecubital ...
Francesco Cavallo+7 more
wiley +1 more source
A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma. [PDF]
In resource-limited areas, such as sub-Saharan Africa, problems in accurate cancer case ascertainment and enumeration of the at-risk population make it difficult to estimate cancer incidence. We took advantage of a large well-enumerated healthcare system
Amerson, Erin+18 more
core
Polypept(o)ide‐Based Core–Shell Bottlebrush Polymers: A Versatile Platform for Drug Encapsulation
This study developed polypept(o)ide‐based core–shell brushes (CSBs) with tunable sizes (Rh: 17–70 nm) for hydrophobic drug delivery. CSBs achieved 10% dasatinib loading through π–π interactions, enabling sustained release over 72 h. Notably, CSB‐dasatinib complexes showed comparable cell viability reduction to the free drug in U‐87 MG cells ...
Bonan Zhao+6 more
wiley +1 more source